502- Psychedelic Therapy for Mood Disorders: Research & Potential

ADHD Experts Podcast

ADDitude

Hallowell, Adhd, Mental Health, 504, Add, Iep, Deficit, Additude, Medication, Disorder, Attention, Health & Fitness

4.6 • 1.3K Ratings

🗓️ 14 May 2024

⏱️ 63 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Learn about new and ongoing research about the safety and efficacy of psychedelic drugs like psilocybin, ketamine, MDMA, and LSD to treat mood disorders and other conditions from Adrian Jacques H. Ambrose, M.D.

Treatment for Mood Disorders: More Resources

Download: Solving the Bipolar and ADHD Puzzle
Self-Test: Depression in Adults
Read: Mental Health’s Psychedelic Revolution
Get: 9 Conditions Often Diagnosed with ADHD

Access the video and slides for podcast episode #502 here: https://www.additudemag.com/webinar/psychedelic-therapy-for-mood-disorders/

Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to the Attention Deficit Disorder Expert Podcast series by Attitude magazine. Hello, my name is Nicole Carr and on behalf of the attitude team, I'm pleased to
0:20.4	welcome you to today's ADHD expert's presentation titled
0:25.0	Psychadelic Therapy for Mood Disorders, Research and Potential.
0:30.0	Leading today's presentation is Dr. Adrian Jock Ambrose.
0:34.4	Dr. Ambrose is the senior medical director of Columbia Doctor's Psychiatry
0:39.7	at Columbia University Irving Medical Center. He specializes in
0:44.0	interventional and novel therapeutics for mood disorders including
0:48.1	transcranial magnetic stimulation, ketamine, and psychedelics. For adult adult child and adolescent populations.
0:56.0	Psychodallics have long sparked interest among researchers, psychiatrists, and patients.
1:02.0	For years, these experimental drugs were embraced for their
1:05.8	therapeutic potential. However the rise of counterculture and the illicit use of
1:10.6	LSD in the 1960s brought a decades long halt to psychedelic research.
1:16.4	It wasn't until 2000 that regulatory approval was granted to study
1:20.9	psychedelics again. In today's webinar Dr Ambrose will share what is known about the
1:26.4	promising potential of silicibin, ketamine, MDMA, and LSD, as well as side effects and questions to ask when considering and
1:33.4	LSD as well as side effects and questions to ask when considering psychedelic usage.
1:36.6	So without any further ado, I'm so pleased to welcome Dr. Adrian Jock Ambrose.
1:42.3	Thank you so much for joining us today
1:44.8	and leading this discussion.
1:48.4	Thank you so much.
1:49.7	And I am very grateful for the opportunity to chat with you all today about psychedelics.
1:56.3	And in my work I've heard from countless patients and their families, there's just so much noise and misinformation right now in this space.
	...

Transcript will be available on the free plan in -275 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from ADDitude, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of ADDitude and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.